Case number 1:19-cv-00154
Genentech, Inc. et al v. Macleods Pharmaceuticals Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 27, 2020 | N/A | Order Administratively Closing Case (0) Docket Text: ORAL ORDER: The case is closed for administrative purposes (see D.I. 159 in Lead Civil Action 19-78-RGA (CASE CLOSED). Ordered by Judge Richard G. Andrews on 8/27/2020. (nms) |
| Aug 27, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 19 has been removed from the docket per D.I. [17]. (nms) |
| Sep 6, 2019 | 18 | Transcript (41) Docket Text: Official Transcript of Scheduling Conference held on 08/20/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/27/2019. Redacted Transcript Deadline set for 10/7/2019. Release of Transcript Restriction set for 12/5/2019. (Triozzi, Heather) |
| Sep 3, 2019 | 17 | Scheduling Order (16) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 11/12/2020. Joint Claim Construction Brief due by 8/26/2020. A Markman Hearing is set for 9/23/2020, at 8:30 AM in Courtroom 6A. A Pretrial Conference is set for 10/22/2021, at 8:30 AM in Courtroom 6A. A Bench Trial is set for 11/8/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) |
| Sep 3, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R. Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:19-cv-00078-RGA et al.(cak) |
| Aug 30, 2019 | 16 | Cover Letter (1) |
| Aug 30, 2019 | 16 | Proposed Order (19) Docket Text: PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # (1) Letter)(Jacobs, Karen) Modified on 8/30/2019 (nms). |
| Aug 20, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 8/20/2019. Local counsel present for plaintiffs: J. Blumenfeld. Local counsel present for defendants: S. Brauerman, A. Orlacchio, S. O'Byrne, S. Stamoulis, A. Gaza, E. Ormerod, B. Schladweiler, J. Parshall, M. Haney, K. Dorsney. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-cv-00078-RGA et al.(crb) |
| Aug 16, 2019 | 15 | Letter to The Honorable Richard G. Andrews (2) |
| Aug 16, 2019 | 15 | Proposed Order (26) Docket Text: PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # (1) Letter)(Jacobs, Karen) Modified on 8/20/2019 (nms). |
| May 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER SETTING RULE 16(b) CONFERENCE: A scheduling conference pursuant to Fed. R. Civ. P. 16(b) will be held on Tuesday, August 20, 2019, at 2:30 p.m., in Courtroom 6A of the Boggs Federal Building, 844 King Street, Wilmington, Delaware. Plaintiffs counsel shall coordinate a dial in number for all parties wishing to participate, but not physically being able to do so. The dial in number will be for listening capacity only. Parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent. The parties shall direct any requests or questions regarding the scheduling or management of this case to the Courts Case Manager at (302) 573-6137. Ordered by Judge Richard G. Andrews on 5/16/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) |
| Apr 24, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Gurpreet Singh Walia, M.D. for Macleods Pharma USA, Inc., for Macleods Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Apr 22, 2019 | 13 | Answer to Counterclaim (20) Docket Text: ANSWER to [10] Answer to Complaint, and Counterclaims, by Genentech, Inc., InterMune, Inc..(Jacobs, Karen) Modified on 4/23/2019 (nms). |
| Apr 8, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Gary Ji for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Apr 5, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Joseph Schramm, III for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Apr 4, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia, M.D., Gary Ji and Joseph Schramm, III, filed by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc.. Signed by Judge Richard G. Andrews on 4/4/2019. (nms) |
| Apr 3, 2019 | 12 | Certification of Gurpreet Singh Walia, M.D. (1) |
| Apr 3, 2019 | 12 | Motion for Leave to Appear Pro Hac Vice (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia, M.D., Gary Ji and Joseph Schramm, III - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Attachments: # (1) Certification of Gurpreet Singh Walia, M.D., # (2) Certification of Gary Ji, # (3) Certification of Joseph Schramm, III)(Haney, Megan) |
| Apr 3, 2019 | 12 | Certification of Gary Ji (1) |
| Apr 3, 2019 | 12 | Certification of Joseph Schramm, III (1) |
| Apr 1, 2019 | 10 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against All Plaintiffs, by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Phillips, John) Modified on 4/2/2019 (nms). |
| Apr 1, 2019 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc. filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Phillips, John) |
| Mar 8, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Ryan Hagglund, Warren K. MacRae, and Mark E. Waddell for Genentech, Inc. and InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00078-RGA et al.(ddp) |
| Feb 13, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to April 1, 2019 (*Reset Answer Deadlines: Macleods Pharma USA, Inc. answer due 4/1/2019; Macleods Pharmaceuticals Ltd. answer due 4/1/2019). Signed by Judge Richard G. Andrews on 2/12/2019. (nms) |
| Feb 12, 2019 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. to move, answer or otherwise respond to the Complaint (D.I. 1) to April 1, 2019 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Phillips, John) |
| Feb 12, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (11 in 19-cv-78-RGA, 8 in 19-cv-154-RGA, 7 in 19-cv-202-RGA, 8 in 19-cv-130-RGA, 9 in 19-cv-103-RGA, 9 in 19-cv-110-RGA, 9 in 19-cv-123-RGA, 8 in 19-cv-205-RGA, 8 in 19-cv-219-RGA, 10 in 19-cv-178-RGA, 13 in 19-cv-131-RGA, 7 in 19-cv-223-RGA, 7 in 19-cv-142-RGA, 7 in 19-cv-136-RGA, 11 in 19-cv-104-RGA, 8 in 19-cv-190-RGA, 7 in 19-cv-141-RGA, 8 in 19-cv-177-RGA, 13 in 19-cv-132-RGA, 9 in 1:19-cv-00120-RGA, 8 in 19-cv-111-RGA, 8 in 19-cv-195-RGA, 9 in 19-cv-105-RGA, 9 in 1:19-cv-00109-RGA, 7 in 19-cv-203-RGA, 10 in 19-cv-164-RGA) MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP filed by Genentech, Inc., InterMune, Inc.. Signed by Judge Richard G. Andrews on 2/12/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) |
| Feb 11, 2019 | 8 | Motion for Leave to Appear Pro Hac Vice (15) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) |
| Feb 8, 2019 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Macleods Pharmaceuticals Ltd. served on 2/7/2019, answer due 2/28/2019. (Blumenfeld, Jack) |
| Feb 6, 2019 | 6 | Return of Service Executed (2) Docket Text: Return of Service Executed by InterMune, Inc., Genentech, Inc.. Macleods Pharma USA, Inc. served on 2/5/2019, answer due 2/26/2019. (Blumenfeld, Jack) |
| Feb 5, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The summons returned executed filed at D.I. 6 has been removed from the docket per counsel's request. The document contained errors. The correct summons returned executed will be filed. (nms) |
| Jan 30, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00120-RGA, 1:19-cv-00123-RGA, 1:19-cv-00130-RGA through 1:19-cv-00132-RGA, 1:19-cv-00136-RGA, 1:19-cv-00141-RGA, 1:19-cv-00142-RGA, 1:19-cv-00154-RGA and 1:19-cv-00164-RGA (rjb) |
| Jan 29, 2019 | N/A | Summons Reissued (0) Docket Text: Summons Reissued with Magistrate Consent Notice attached as to Macleods Pharmaceuticals Ltd.. (sar) |
| Jan 28, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Macleods Pharma USA, Inc. on 1/28/2019; Macleods Pharmaceuticals Ltd. on 1/28/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sar) |
| Jan 28, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holding Ltd., Corporate Parent Novartis Ltd., Corporate Parent Roche Holdings, Inc. for Genentech, Inc.; Corporate Parent Genentech Inc. for InterMune, Inc. filed by Genentech, Inc., InterMune, Inc.. (sar) |
| Jan 28, 2019 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,767,225, B2 ;7,988,994 B2 ;8,383,150 B2 ;8,753,679 B2 ;7,696,236 B2. (sar) |
| Jan 28, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: December 19, 2018. Date of Expiration of Patent: September 22, 2026 through August 30, 2033.Thirty Month Stay Deadline: 4/15/2022. (sar) |
| Jan 28, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) |
| Jan 28, 2019 | 1 | Civil Cover Sheet (2) |
| Jan 28, 2019 | 1 | Exhibit 1-19 (293) |
| Jan 28, 2019 | 1 | Complaint* (1) |
